A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.
Agilent (A) reported earnings 30 days ago. What's next for the stock?
Canadian Apartment Properties REIT trades at 15x AFFO and nearly 40% below NAV, offering compelling value. Q1 AFFO per share declined just 1.5% to C$0.513, with a strong 70% payout ratio and robust distribution coverage. Active buybacks and retained AFFO (~C$100 million/year) support growth initiatives and the development pipeline.
Investors need to pay close attention to A stock based on the movements in the options market lately.
The iShares Large Cap Core Active ETF is a highly concentrated, actively managed fund that has outperformed many similar ETFs since its inception in October 2023. BLCR's managers intentionally deviate from consensus, focusing on long-term earnings growth and momentum, differentiating it from passive Index funds. Fundamental analysis reveals an expensive portfolio, both relative to its peers and itself, based on its 5Y average P/E. Quality is also behind another active BlackRock ETF that I prefer.
Examine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
A beat Q2 estimates and raised its fiscal 2026 outlook. It says its Ignite operating system is driving more durable gains in pricing, execution and margins.
Agilent Technologies, Inc. (A) Q2 2026 Earnings Call Transcript
Agilent Technologies NYSE: A raised its fiscal 2026 outlook after reporting stronger-than-expected second-quarter results, with management pointing to broad-based demand, instrument replacement momentum, pricing actions and operational gains from its Ignite operating system.
The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended April 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Agilent Technologies (A) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.4 per share. This compares to earnings of $1.31 per share a year ago.
Life sciences firm Agilent Technologies raised its 2026 adjusted profit forecast on Wednesday, anticipating strong demand for its medical tools and equipment used in lab research and diagnostic services.